Trial Details
TERMINATEDBasic Information
| Clinical ID | c1714 |
|---|---|
| Identifier | NCT04629196 |
| Trial Title | Induction Optimization With Stelara for Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Ustekinumab|DRUG: Ustekinumab|DRUG: Ustekinumab |
Participant Information
| Sponsor | NYU Langone Health |
|---|---|
| City | Baltimore |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2022-02-16 |
|---|---|
| Primary Completion Date | 2024-01-17 |
| Completion Date | 2024-01-17 |